http://www.fpnotebook.com/
FludrocortisoneAka: Florinef
- Mechanism
- Systemic Corticosteroid
- Expands intravascular volume
- Indications
- Adrenal Insufficiency
- Orthostatic Hypotension (some forms)
- Adverse Effects
- Volume overload
- Hypokalemia
- Hypomagnesemia
- Headache
- Edema
- Weight gain
- Supine Hypertension
- References
- (2003) Lexi-comp Drug Database
Fludrocortisone (C0016280) | |
|---|---|
| Definition (MSH) | A synthetic mineralocorticoid with anti-inflammatory activity. |
| Definition (NCI) | A synthetic corticosteroid. It is used to replace steroid hormones normally produced by the adrenal gland. |
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125) |
| MSH | D005438 |
| English | 9 alpha Fludrohydrocortisone, 9 alpha Fluoro 17 Hydroxycorticosterone, 9 alpha Fluorohydrocortisone, 9 alpha-Fluoro-17-Hydroxycorticosterone, 9 alpha-Fluorohydrocortisone, 9 Fluoro 17 Hydroxycortisone, 9 Fluorocortisol, 9 Fluorohydrocortisone, 9-Fluoro-17-Hydroxycortisone, 9-Fluorocortisol, 9-Fluorohydrocortisone, Fludrocortisone, Fludrocortisone preparation, FLUOROCORTISOL 09 |
| Spanish | fludrocortisona, preparado con fludrocortisona, preparado de fludrocortisona |
| Parent Concepts | Hydrocortisone (C0020268), Mineralocorticoids (C0026160), Pregnenediones (C0033013), Synthetic mineralocorticoid (C0026161), Synthetic glucocorticoid, fluorinated (C1289952) |
| Sources | CSP, LNC, MSH, NCI, NDFRT, PDQ, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Florinef (C0060486) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) |
| MSH | C034635 |
| English | Bristol-Myers Squibb brand of fludrocortisone 21-acetate, Florinef, Florinef acetate, Monarch brand of fludrocortisone 21-acetate, Shire brand of fludrocortisone 21-acetate |
| Sources | MSH, NCI, PDQ, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
